A detailed history of Relative Value Partners Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Relative Value Partners Group, LLC holds 16,151 shares of NVO stock, worth $1.41 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
16,151
Holding current value
$1.41 Million
% of portfolio
0.31%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $1.98 Million - $2.37 Million
16,151 New
16,151 $2.31 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Relative Value Partners Group, LLC Portfolio

Follow Relative Value Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.